Navigation Links
Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
Date:12/21/2010

LITTLETON, Mass., Dec. 21, 2010 /PRNewswire/ --Audax Medical, Inc. (www.audaxmed.com), a privately held medical device company specializing in the development of orthobiologics, has been awarded a research and development grant through the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was established under the Patient Protection and Affordable Care Act of 2010 to support therapeutic projects that are innovative, reduce long-term healthcare costs, and/or address unmet medical needs.

The company recently announced its partnership with Brown University in the development of its core technology, Arxis™, for the regeneration of diseased bone, cartilage, and other soft tissues. The grant approval validates the strong clinical need for a cost-effective, minimally invasive solution, such as Arxis™, in orthopedic medicine.

"We are delighted to receive this recognition and funding to support the development of Arxis™. This further validates the clinical significance of our technology and the company's commitment to regenerative medicine," stated Mark A. Johanson, President and CEO of Audax.

Audax's growing technology portfolio demonstrates significant promise in multiple areas of bone and tissue preservation. The QTDP grant directly supports the company's dynamic research and development efforts in tissue regeneration, tissue reconstruction, drug delivery, and combination products. Most importantly, the funding will contribute to the company's commercialization of Arxis™, which will impact the lives of patients suffering from debilitating orthopedic conditions.

About Audax Medical, Inc.

Audax Medical, Inc. is a privately held medical device company located in Littleton, Massachusetts. The company offers innovative solutions for the treatment of degenerative bone and musculoskeletal tissue. The company's products go beyond simply stabilizing a clinical deficiency by promoting the growth of natural bone and tissue. With enhanced surgical based solutions and osteogenic biomaterial technologies, Audax offers a modern alternative to existing orthopedic therapies.  For more information visit, www.audaxmed.com


'/>"/>
SOURCE Audax Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Audax Medical, Inc. Secures Exclusive Rights to Novel Osteobiologic Nanotechnology
2. Prescient Medical, Inc. Presenting at the 5th Annual Canaccord Genuity Cardiovascular Conference
3. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
4. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
5. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
6. China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
7. Nonin Medical, Inc. Announces Capnography Division Name Change; Expands Swedish Manufacturing Facility to Become Full-Franchise European Sales, Distribution and Service Center
8. CSA Medical, Inc. Announces 75th Customer
9. Len DeBenedictis Retires as Chief Technology Officer of Solta Medical, Inc.
10. BlueDot Medical, Inc. Named to 2010 Inc. 500/5000
11. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology:
(Date:9/21/2017)... ... September 21, 2017 , ... The American ... Health Services for professionals in the addiction treatment industry entitled: Special Investigations ... , Insurance companies and state and federal governments are increasingly scrutinizing the addiction ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... communities, nine governmental public health departments have been awarded five-year accreditation status through ... that the benefits of being served by a PHAB-accredited health department now ...
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum will demonstrate capabilities of ... Healthcare Conference 2017 in Chicago, IL on October 17-19, 2017. This unique development ... improving patient safety. , Microscan , a global technology leader in ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, Fumie and Kentaro Mune, ... and 8th October at Miranda Kuo Gallery on Lower East Side, NYC. This exhibition ... Kodo mat. Wanderlust , one of the largest US yoga online media outlets ...
(Date:9/21/2017)... ... September 21, 2017 , ... Sagora Senior Living, ... Isle at Kingwood Assisted Living and Memory Care located at 24025 Kingwood Place ... 55 assisted living apartments, 43 memory care apartments and 23 extended care apartments. ...
Breaking Medicine News(10 mins):